Articles
One-year budget impact of InTandem™: a novel neurorehabilitation system for individuals with chronic stroke walking impairment
- Journal/Conference:
- JCER
- Author(s):
- Kirsten E Smayda, Jennifer Lavanture, Megan Bourque, Nathashi Jayawardena, Sarah Kane, Holly Roberts, and Barbara Heikens
- Publication Date:
- 2024
- Condition:
- Stroke
Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies
- Journal/Conference:
- BMC Neurology
- Author(s):
- Robert Zivadinov, Alexander J. Keenan, Hoa H. Le, Maria Ait-Tihyaty, Kavita Gandhi, Matthew L. Zierhut, Elizabeth M. Salvo-Halloran, Abril Oliva Ramirez, Vivian Vuong, Sumeet Singh, Brian Hutton
- Publication Date:
- 2024
- Condition:
- Multiple Sclerosis
Systematic literature review of real-world evidence for treatments in HR+/HER2- second-line LABC/mBC after first-line treatment with CDK4/6i
- Journal/Conference:
- BMC Cancer
- Author(s):
- Veronique Lambert 1, Sarah Kane # 2, Belal Howidi # 2, Bao-Ngoc Nguyen # 2, David Chandiwana 3, Yan Wu 1, Michelle Edwards 3, Imtiaz A Samjoo
- Publication Date:
- 2024
- Condition:
- Breast Cancer
Efficacy and safety of crizotinib in the treatment of advanced non-small cell lung cancer with ROS1 gene fusion: a systematic literature review and meta-analysis of real-world evidence
- Journal/Conference:
- Lung Cancer
- Author(s):
- Ernest Nadal 1, Nada Rifi 2, Sarah Kane 3, Sokhna Mbacke 3, Lindsey Starkman 3, Beatrice Suero 3, Hannah Le 2, Imtiaz A Samjoo
- Publication Date:
- 2024
- Condition:
- Lung Cancer
Artificial Intelligence in Real-World Evidence Generation: Systematic Review of Applications and Challenges
- Journal/Conference:
- 2024-11, ISPOR Europe 2024, Barcelona, Spain
- Author(s):
- Verma A1, Patel N1, Krishna A1, Pruthi J1, Rai MK2, Prasanna R | 1 1EVERSANA, Mumbai, India, 2EVERSANA, Singapore, Singapore
- Publication Date:
- Value in Health, Volume 27, Issue 12, S2 (December 2024)
The Effectiveness of Telemedicine in Improving Access to Healthcare Services: A Systematic Review
- Journal/Conference:
- 2024-11, ISPOR Europe 2024, Barcelona, Spain
- Author(s):
- Jangid S1, Vishnubhotla M2, Prasanna R3, Rai MK3 | 1EVERSANA, Mumbai, MH, India, 2Eversana, HYDERABAD, Telangana, India, 3EVERSANA, Singapore, Singapore
- Publication Date:
- Value in Health, Volume 27, Issue 12, S2 (December 2024)
Cost-Effectiveness Analysis of 1.5% Ruxolitinib Cream for the Treatment of Patients With Atopic Dermatitis in Canada
- Journal/Conference:
- 2024-11, ISPOR Europe 2024, Barcelona, Spain
- Author(s):
- Pastor L1, Hughes-Martin A1, Cameron H1, Marino R2, Larbi M3 1EVERSANA, Burlington, ON, Canada, 2Incyte Corporation, Wilmington, DE, USA, 3Incyte Biosciences Canada, Pointe Claire, QC, Canada
- Publication Date:
- Value in Health, Volume 27, Issue 12, S2 (December 2024)
Role of Health-Economics Application in Enhancing Personalized Medicine: A Comprehensive Systematic Review
- Journal/Conference:
- 2024-11, ISPOR Europe 2024, Barcelona, Spain
- Author(s):
- Jangid S1, Verma A1, Krishna A1, Pruthi J1, Prasanna R1, Rai MK2 | 1EVERSANA, Mumbai, MH, India, 2EVERSANA, Singapore, Singapore
- Publication Date:
- Value in Health, Volume 27, Issue 12, S2 (December 2024)
A Literature Review to Identify Prognostic Factors and Treatment Effect Modifiers in Population-Adjusted Indirect Comparisons for Multiple Myeloma
- Journal/Conference:
- 2024-11, ISPOR Europe 2024, Barcelona, Spain
- Author(s):
- Chiang K1, He J2, Kwong WJ2, Lin X2, Yang L2, Keng MJ3, Nair S3, Hashim M4, Samjoo I | 1 1EVERSANA, Burlington, ON, Canada, 2Janssen Global Services, Raritan, NJ, USA, 3Janssen Pharmaceutica NV, Beerse, Belgium, 4Janssen Pharmaceutica NV, Rotterdam, ZH, Netherlands
- Publication Date:
- Value in Health, Volume 27, Issue 12, S2 (December 2024)
- Condition:
- Oncology
Health Economics Studies Assessment of the 2ND China Rare Disease Catalogue: A Scoping Review
- Journal/Conference:
- 2024-11, ISPOR Europe 2024, Barcelona, Spain
- Author(s):
- Fang J1, Du H1, Tjong A Hung I1, Rai MK2, Cameron C3 | 1EVERSANA (Shanghai) Consulting Co., Ltd., Shanghai, China, 2EVERSANA, Singapore, Singapore, 3EVERSANA, Sydney , NS, Canada
- Publication Date:
- Value in Health, Volume 27, Issue 12, S2 (December 2024)
- Condition:
- Rare & Orphan Diseases